Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Arbutus Biopharma Corp changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 163 | 1 | 166 | +4 |
| Shares | 118.1M | 18.7K | 118.2M | +75.0K (+0.1%) |
| Value | $365.0M | $57.6K | $536.4M | +$171.5M (+47.0%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Arbutus Biopharma Corp at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Western Standard LLC | 507,853 | $2.31M | 1.23% |
| StemPoint Capital LP | 205,388 | $932.5K | 0.19% |
| Murchinson Ltd. | 200,000 | $908.0K | 0.18% |
| Arrowstreet Capital, Limited Partnership | 159,118 | $722.4K | 0.00% |
| Balyasny Asset Management LLC | 107,665 | $488.8K | 0.00% |
| Campbell & CO Investment Adviser LLC | 73,285 | $332.7K | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 66,056 | $299.9K | 0.01% |
| Rockefeller Capital Management L.P. | 63,000 | $286.0K | 0.00% |
| Quantinno Capital Management LP | 35,896 | $163.0K | 0.00% |
| Jain Global LLC | 26,000 | $118.0K | 0.00% |
| Omers Administration Corp | 21,700 | $98.5K | 0.00% |
| CIBC Bancorp USA Inc. | 16,138 | $73.3K | 0.00% |
| Graham Capital Management, L.P. | 13,265 | $60.2K | 0.00% |
| State of Wisconsin Investment Board | 12,863 | $58.4K | 0.00% |
| Voleon Capital Management LP | 10,403 | $47.2K | 0.00% |
| Optiver Holding B.V. | 2,181 | $9.90K | 0.00% |
| Aster Capital Management (DIFC) Ltd | 1,961 | $8.90K | 0.00% |
| Larson Financial Group LLC | 739 | $3.35K | 0.00% |
| Quadrant Capital Group LLC | 277 | $1.26K | 0.00% |
| Farther Finance Advisors, LLC | 256 | $1.16K | 0.00% |
| Bare Financial Services, Inc | 181 | $822 | 0.00% |
Sold out (17)
Institutions that held Arbutus Biopharma Corp at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| UBS Asset Management Americas Inc | 1,072,744 | $3.31M |
| Eisler Capital Management Ltd. | 276,375 | $851.2K |
| Franklin Resources Inc | 104,423 | $322.7K |
| Caption Management, LLC | 41,866 | $129.4K |
| Los Angeles Capital Management LLC | 19,655 | $60.7K |
| Axq Capital, LP | 18,545 | $57.3K |
| Colony Group, LLC | 17,821 | $55.1K |
| Kestra Advisory Services, LLC | 14,000 | $43.3K |
| Two Sigma Advisers, LP | 13,900 | $43.0K |
| LPL Financial LLC | 12,147 | $37.5K |
| Oxford Asset Management LLP | 12,143 | $37.5K |
| Ameriprise Financial Inc | 11,440 | $35.4K |
| Two Sigma Investments, LP | 11,299 | $34.9K |
| Raymond James Financial Inc | 8,504 | $26.3K |
| IFP Advisors, Inc | 0 | $7.04K |
| Caitong International Asset Management Co., Ltd | 784 | $2.42K |
| Skopos Labs, Inc. | 395 | $1.22K |
Not filed for Q3 2025 yet (1)
Institutions that held Arbutus Biopharma Corp at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| CIBC World Markets Corp | 18,653 | $57.6K |